Tobacco stocks rally as FDA considers banning all flavored e-cigarettes
Tobacco company shares rose in active Wednesday morning trade after the Food and Drug Administration chief said that the agency might ban all flavored e-cigarettes due to their popularity among teenagers, which he said had reached "an epidemic proportion." British American Tobacco BATS, +5.87% shares rose 6.3% in extremely heavy Wednesday trade, Altria Group Inc. MO, +6.94% shares rose 7% in extremely active trade and Philip Morris International Inc. PM, +3.89% stock rose nearly 5% in heavy trade.
Altria Reports 2018 Second-Quarter and First-Half Results; Tightens 2018 Full-Year Earnings Guidance
Measurements of electronic cigarette-generated particles for the evaluation of lung cancer risk of active and passive users
The use of electronic cigarettes as an alternative to traditional cigarettes, in the described conditions and considering typical habits for Italian smokers, reduces the risk to get lung cancer from about 4×10−1 to about 7×10−6 (40,000 additional cases versus 0.7 additional cases over a population of 100,000). The exposure to second-hand aerosol, instead, determines a negligible increment of lung cancer cases (0.001–0.003 new cases over a population of 100 000). Higher risks are associated to ECs with nicotine due to the presence of NNN and NNK. In particular, NNK, As and Cd are the main contributors to the total ELCR for ECs with nicotine, while for ECs without nicotine, the main contributor is Cd.
Quit Methods Used by American Smokers, 2013–2014
Use of e-cigarettes was the only method with higher odds of users being a former smoker than unaided attempts (OR = 1.42, 95% CI 1.12–1.81). Current use of e-cigarettes among current (34%) and former (54%) smokers was significantly higher than current use of nicotine replacement therapy (NRT). Conclusions: In 2013–2014 e-cigarettes were used by American adult smokers as quit-smoking aids more frequently than NRT products or prescription drugs.
= new reply since forum marked as read